ZA200810600B - Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists - Google Patents

Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Info

Publication number
ZA200810600B
ZA200810600B ZA200810600A ZA200810600A ZA200810600B ZA 200810600 B ZA200810600 B ZA 200810600B ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 B ZA200810600 B ZA 200810600B
Authority
ZA
South Africa
Prior art keywords
tumors
treatment
growth factor
receptor antagonists
factor receptor
Prior art date
Application number
ZA200810600A
Other languages
English (en)
Inventor
Rowinsky Eric
Original Assignee
Imclone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Systems Inc filed Critical Imclone Systems Inc
Publication of ZA200810600B publication Critical patent/ZA200810600B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200810600A 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists ZA200810600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83348706P 2006-07-27 2006-07-27

Publications (1)

Publication Number Publication Date
ZA200810600B true ZA200810600B (en) 2009-11-25

Family

ID=38982334

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810600A ZA200810600B (en) 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Country Status (15)

Country Link
EP (1) EP2043688A4 (fr)
JP (1) JP2009544736A (fr)
KR (1) KR20090033841A (fr)
CN (1) CN101484186A (fr)
AU (1) AU2007279261A1 (fr)
BR (1) BRPI0712368A2 (fr)
CA (1) CA2654911A1 (fr)
CR (1) CR10486A (fr)
EA (1) EA200870603A1 (fr)
EC (1) ECSP089011A (fr)
MX (1) MX2008016187A (fr)
NO (1) NO20085182L (fr)
TN (1) TNSN08512A1 (fr)
WO (1) WO2008014386A2 (fr)
ZA (1) ZA200810600B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021019167A2 (pt) * 2019-03-27 2021-12-21 Nat Res Council Canada Anticorpos anti-egfrviii e fragmentos de ligação a antígeno dos mesmos

Also Published As

Publication number Publication date
TNSN08512A1 (en) 2010-04-14
CN101484186A (zh) 2009-07-15
EP2043688A4 (fr) 2009-11-11
WO2008014386A2 (fr) 2008-01-31
EP2043688A2 (fr) 2009-04-08
BRPI0712368A2 (pt) 2012-06-05
KR20090033841A (ko) 2009-04-06
CA2654911A1 (fr) 2008-01-30
EA200870603A1 (ru) 2009-06-30
JP2009544736A (ja) 2009-12-17
MX2008016187A (es) 2009-01-20
AU2007279261A1 (en) 2008-01-31
WO2008014386A3 (fr) 2008-07-03
NO20085182L (no) 2009-04-24
CR10486A (es) 2009-02-23
ECSP089011A (es) 2009-01-30

Similar Documents

Publication Publication Date Title
IL281715A (en) Activin-ActrIIA antagonists and their use to increase bone growth in cancer patients
HRP20190092T1 (hr) Antitijela i cjepiva za uporabu u terapijskim i dijagonstičkim postupcima za poremećaje vezane uz alfa-sinuklein
EP2131919A4 (fr) Dispositif implantable destiné à communiquer avec le tissu biologique
IL211952A0 (en) Implantable device for the delivery of risperidone and methods of use thereof
PL2426148T3 (pl) Przeciwciało anty-IL-3RA do stosowania w leczeniu nowotworu krwi
PL2205185T3 (pl) Urządzenie do wytwarzania zakotwiczenia w tkance ludzkiej lub zwierzęcej
EP2178455A4 (fr) Dispositif de traitement pour un tissu vivant
BRPI1007877A2 (pt) "inibidores de dpp-iv para o tratamento de diabetes em pacientes pediátricos"
IL230911A0 (en) A system for the treatment of heart tissue and its use
IL213410A0 (en) Methods and compositions for diagnostic use in cancer patients
EP1991284A4 (fr) Bio-implants pour la stimulation de la croissance tissulaire
EP2317934A4 (fr) Procédés et dispositifs permettant de pratiquer des sutures dans un tissu
IL197157A0 (en) Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase
ZA201102949B (en) Implantable device for the delivery of octreotide and methods of use thereof
HK1203160A1 (en) Tapentadol for the treatment of pain in arthrosis (tapentadol)
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
PL2227210T3 (pl) Łóżko pacjenta z urządzeniem nadzorującym i terapeutycznym
EP2421548A4 (fr) Utilisation de (hexénoyl trans-3)hgrf(1-44)nh2 et de simvastatine dans un traitement combiné
EP2271267A4 (fr) Dispositifs médicaux pour administrer des fluides pendant une chirurgie et leurs procédés d'utilisation
EP2334304A4 (fr) Croissance et régénération osseuses thérapeutiques
GB0822486D0 (en) Compounds for use in the treatment of pain
PT2320900T (pt) Utilização de opioides ou miméticos de opioides para o tratamento de pacientes com cancros resistentes
ZA200810600B (en) Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists
EP2124950A4 (fr) Traitement d'une douleur avec de la naloxone
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders